Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Methyl (S)-3-methyl-2-((2’-(1-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl-methyl) amino) butanoate hydrobromide is a derivative of Valsartan, a non-peptide, angiotensin II antagonist acting on the AT1 receptor subtype and useful for the prophylaxis and treatment of diseases or the conditions, which may be inhibited by blocking the ATI receptor, such as high blood pressure and cardiac insufficiency.
?您的位置：
